Status:

NOT_YET_RECRUITING

Combined Use of Naldebain® ER Injection and Precedex® After VATS

Lead Sponsor:

Kaohsiung Medical University Chung-Ho Memorial Hospital

Conditions:

Acute Post Operative Pain

Chronic Post Operative Pain

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The goal of this clinical trial is to investigate the effects of combined use of Naldebain® ER Injection and Precedex® in patients received video-assisted thoracoscopic surgery. The main questions it ...

Detailed Description

Ⅰ.Protocol title: To investigate the effects of combined use of Naldebain® ER Injection and Precedex® after video-assisted thoracoscopic surgery Ⅱ.Objectives: Video-assisted thoracoscopic surgery (VA...

Eligibility Criteria

Inclusion

  • Subject's age: 18\~65 years old
  • ASA classification: I\~III

Exclusion

  • Patients who need postoperative pain relief due to thoracoscopic surgery

Key Trial Info

Start Date :

December 28 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2026

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT06176222

Start Date

December 28 2023

End Date

March 31 2026

Last Update

December 19 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hung-Te Hsu

Kaohsiung City, Taiwan, 833